Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2019, Article ID 1610632, 6 pages
https://doi.org/10.1155/2019/1610632
Case Report

Development of Multiple Myeloma of the IgA Type in a Patient with Cold Agglutinin Disease: Transformation or Coincidence?

1Section of Hematology, Department of Medicine, Haukeland University Hospital, Bergen, Norway
2Department of Pathology, Akershus University Hospital, Lørenskog, Norway
3Department of Research and Innovation, Haugesund Hospital, Haugesund, Norway

Correspondence should be addressed to Sigbjørn Berentsen; on.ttenguah@nestnereb.nrojbgis

Received 31 October 2018; Accepted 12 February 2019; Published 4 March 2019

Academic Editor: Masayuki Nagasawa

Copyright © 2019 Øystein Sefland et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Michel, “Classification and therapeutic approaches in autoimmune hemolytic anemia: an update,” Expert Review of Hematology, vol. 4, no. 6, pp. 607–618, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Berentsen, “Cold agglutinin disease,” Hematology American Society of Hematology Education Program, vol. 2016, no. 1, pp. 226–231, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Berentsen, “How i manage patients with cold agglutinin disease,” British Journal of Haematology, vol. 181, no. 3, pp. 320–330, 2018. View at Publisher · View at Google Scholar · View at Scopus
  4. U. Randen, G. Troen, A. Tierens et al., “Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma,” Haematologica, vol. 99, no. 3, pp. 497–504, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Ulvestad, S. Berentsen, K. Bø, and F. V. Shammas, “Clinical immunology of chronic cold agglutinin disease,” European Journal of Haematology, vol. 63, no. 4, pp. 259–266, 1999. View at Publisher · View at Google Scholar
  6. P. L. Swiecicki, L. T. Hegerova, and M. A. Gertz, “Cold agglutinin disease,” Blood, vol. 122, no. 7, pp. 1114–1121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Berentsen, E. Ulvestad, R Langholm et al., “Primary chronic cold agglutinin disease: a population based clinical study of 86 patients,” Haematologica, vol. 91, no. 4, pp. 460–466, 2006. View at Google Scholar
  8. C. D. Angevine, B. R. Andersen, and E. V. Barnett, “A cold agglutinin of the IgA class,” Journal of Immunology, vol. 96, no. 4, pp. 578–586, 1966. View at Google Scholar
  9. C. Chic Acevedo, E. García Torres, and M. Á. Álvarez Rivas, “Enfermedad por crioaglutinina del subtipo IgA como manifestación temprana de mieloma múltiple y resolución tras tratamiento con nuevos fármacos anti-mieloma,” Medicina Clínica, vol. 147, no. 11, pp. e63–e64, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Berentsen, E. Ulvestad, B. T. Gjertsen et al., “Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients,” Blood, vol. 103, no. 8, pp. 2925–2928, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Rossi, D. Gramegna, F. Paoloni et al., “Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study,” Blood, vol. 132, no. 5, pp. 547–550, 2018. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Schöllkopf, L. Kjeldsen, O. W. Bjerrum et al., “Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients,” Leukemia & Lymphoma, vol. 47, no. 2, pp. 253–260, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Berentsen, U. Randen, M. Oksman et al., “Bendamustine plus rituximab for chronic cold agglutinin disease: results of a nordic prospective multicenter trial,” Blood, vol. 130, no. 4, pp. 537–541, 2017. View at Publisher · View at Google Scholar · View at Scopus
  14. R. de Tute, A. Rawstron, P. Evans, and R. Owen, “Cold agglutinin disease is a phenotypically distinct clonal B-cell disorder,” Clinical Lymphoma Myeloma and Leukemia, vol. 15, p. e184, 2015. View at Publisher · View at Google Scholar
  15. A. Malecka, G. Trøen, A. Tierens et al., “Frequent somatic mutations of KMT2D (MLL2) and CARD11 genes in primary cold agglutinin disease,” British Journal of Haematology, vol. 183, no. 5, pp. 838–842, 2018. View at Publisher · View at Google Scholar
  16. C. Arthold, C. Skrabs, G. Mitterbauer-Hohendanner et al., “Cold antibody autoimmune hemolytic anemia and lymphoproliferative disorders: a retrospective study of 20 patients including clinical, hematological, and molecular findings,” Wiener Klinische Wochenschrift, vol. 126, no. 11-12, pp. 376–382, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Harboe, R. van Furth, H. Schubothe, K. Lind, and R. S. Evans, “Exclusive occurrence of k chains in isolated cold haemagglutinins,” Scandinavian Journal of Haematology, vol. 2, no. 3, pp. 259–266, 1965. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Barcellini, “New insights in the pathogenesis of autoimmune hemolytic anemia,” Transfusion Medicine and Hemotherapy, vol. 42, no. 5, pp. 287–293, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. O. Landgren, R. A. Kyle, and S. V. Rajkumar, “From myeloma precursor disease to multiple myeloma: new diagnostic concepts and opportunities for early intervention,” Clinical Cancer Research, vol. 17, no. 6, pp. 1243–1252, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. R. A. Kyle, ““Benign” monoclonal gammopathy-after 20 to 35 years of follow-up,” Mayo Clinic Proceedings, vol. 68, no. 1, pp. 26–36, 1993. View at Publisher · View at Google Scholar · View at Scopus
  21. N. C. Munshi and S. Jagannath, “Plasma cell neoplasms,” in Hematology: Basic Principles and Practice, R. Hoffman, E. J. Benz, L. E. Silberstein et al., Eds., pp. 1381–1418, Elsevier, Philadelphia, PA, USA, 7th edition, 2017. View at Google Scholar
  22. G. Garratty, L. D. Petz, I. Brodsky, and H. H. Fudenberg, “An IgA high-titer cold agglutinin with an unusual blood group specificity within the Pr complex,” Vox Sanguinis, vol. 25, no. 1, pp. 32–38, 1973. View at Publisher · View at Google Scholar
  23. H. Tonthat, H. Rochant, A. Henry, M. Leporrier, and B. Dreyfus, “A new case of monoclonal IgA kappa cold agglutinin with anti-Pr(1)d specificity in a patient with persistent HB antigen cirrhosis,” Vox Sanguinis, vol. 30, no. 6, pp. 464–468, 1976. View at Publisher · View at Google Scholar
  24. A. Pereira, R. Mazzara, L. Escoda, I. Alcorta, B. Nomdedeu, and D. Roelcke, “Anti-Sa cold agglutinin of IgA class requiring plasma-exchange therapy as early manifestation of multiple myeloma,” Annals of Hematology, vol. 66, no. 6, pp. 315–318, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Römer, U. Rother, and D. Roelcke, “Failure of IgA cold agglutinin to activate C,” Immunobiology, vol. 157, no. 1, pp. 41–46, 1980. View at Publisher · View at Google Scholar · View at Scopus
  26. D. A. Clark, E. N. Dessypris, D. E. Jenkins Jr., and S. B. Krantz, “Acquired immune hemolytic anemia associated with IgA erythrocyte coating: investigation of hemolytic mechanisms,” Blood, vol. 64, no. 5, pp. 1000–1005, 1984. View at Google Scholar
  27. P. Chadebech, M. Michel, D. Janvier et al., “IgA-mediated human autoimmune hemolytic anemia as a result of hemagglutination in the spleen, but independent of complement activation and Fc RI,” Blood, vol. 116, no. 20, pp. 4141–4147, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Berentsen, “Complement activation and inhibition in autoimmune hemolytic anemia: focus on cold agglutinin disease,” Seminars in Hematology, vol. 55, no. 3, pp. 141–149, 2018. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Shi, E. L. Rose, A. Singh et al., “TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins,” Blood, vol. 123, no. 26, pp. 4015–4022, 2014. View at Publisher · View at Google Scholar · View at Scopus